Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Diaceutics announces "Precision Medicine in Oncology " Virtual Event: A Cutting-Edge Exploration of Cancer Diagnostics & Treatment


News provided by

Labroots

Jun 10, 2024, 15:00 ET

Share this article

Share toX

Share this article

Share toX


Diaceutics PLC (AIM: DXRX), a leading technology & solutions provider to the pharma & biotech industry, is pleased to announce its upcoming virtual event. "Precision medicine in oncology," on 19 June, 2024.

BELFAST, Northern Ireland and LONDON, June 10, 2024 /PRNewswire-PRWeb/ -- Diaceutics PLC (AIM: DXRX), a leading technology & solutions provider to the pharma & biotech industry, is pleased to announce its upcoming virtual event. "Precision medicine in oncology," on 19 June, 2024.

This groundbreaking event will take attendees to the forefront of cancer testing & treatment through a series of eight live webinars, culminating in a full day of immersive, true-to-life virtual experiences. The sessions will cover cutting-edge topics that are revolutionising cancer analysis & diagnostics, including immunotherapy, liquid biopsy, pre-analytical phase, NGS, cytology, & CE-IVDR. Participants will gain firsthand insights from top laboratory experts, enhancing their understanding of these critical advancements.

This groundbreaking event will take attendees to the forefront of cancer testing & treatment through a series of eight live webinars, culminating in a full day of immersive, true-to-life virtual experiences.

Post this

Event Speakers will include:

  • Prof. Dr. Klaus Pantel, Director of the Institute of Tumor Biology at the University Medical Center Hamburg-Eppendorf, Germany: Presenting "Implementation of Liquid Biopsy in Precision Oncology," Dr Pantel, a pioneer in cancer cell research, will provide a comprehensive introduction & review to the evolution of precision medicine, focusing on the implementation of liquid biopsy in precision oncology.
  • Dr. Bob Holt, Senior Precision Medicine Strategy Advisor at Diaceutics: Presenting "MRD in Solid Tumor & Hematological Indications: Today & Tomorrow," Dr Holt will analyse the clinical utility & technology behind Minimal Residual Disease (MRD). This session will be followed by Prof. Maria Teresa Voso, Prof. of Hematology at Tor Vergata University, who will discuss the pros & cons of of MRD in AML & engage in a discussion with Dr. Holt & all attendees.
  • Prof. Paul Hoffman, Professor of Pathology at the University Côte d'Azur, Nice France: Presenting on "New challenges in early-stage cancer". This presentation will explore early detection & management of early-stage cancers.
  • Dr. Clare Turnbull PhD FRCP FRCPath FFPH, Professor of Translational Cancer Genetics in the Division of Genetics & Epidemiology at the Institute of Cancer Research NHS Honorary Consultant in Clinical Cancer Genetics, London & Dr. Nicola Normanno, MD, Director of Translational Research, National Cancer Institute, Italy Pascale Foundation, Italy: Presenting "The Role of Comprehensive Genomic Profiling in Precision Oncology," this session promises insights into the implications of large NGS panels, co-mutations, & the introduction of patients harboring germline variants.
  • Prof. Sophie Prévot, Pathologist at the Bicêtre Hospital, Paris: Presenting "Integrating AI in Pathology: Advancing Diagnoses & Workflow Efficiency," this presentation will explore how AI tools can support doctors in making accurate diagnoses & enhancing workflow efficiency.

Ryan Keeling, CEO of Diaceutics, commented, "Our commitment is to challenge the landscape of cancer treatment through precision medicine. This event provides an unparalleled platform for experts to share innovative practices & insights that will shape the future of oncology diagnostics. We are excited to host this gathering of thought leaders & advance our mission of ensuring every patient receives the right treatment at the right time."

The event is tailored for laboratory professionals, pathologists, & anyone involved in oncology diagnostics & treatment. In addition to the expert presentations, attendees can participate in interactive sessions, visit the poster hall, & engage in real-time Q&A sessions with expert speakers.

For further information about the event & to register for free, click here.

About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test & the right therapy to positively impact their disease outcome.

We provide the world's leading pharma & biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific & advisory services enabled by our platform DXRX – The Diagnostics Network®

About Labroots
Labroots is the leading scientific social networking website, & primary source for scientific trending news & premier educational virtual events & webinars & more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks & communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration & learning. Offering more than articles & webcasts that go beyond the mundane & explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars & virtual events.

Media Contact

Akshay Masand, Labroots, + 1.714.463.4673, [email protected], https://www.labroots.com/

SOURCE Labroots

Modal title

Diaceutics announces "Precision Medicine in Oncology " Virtual Event
Diaceutics announces "Precision Medicine in Oncology " Virtual Event
Diaceutics announces "Precision Medicine in Oncology " Virtual Event

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.